Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher N Hahn

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Nature Genetics|December 28, 2011
Spliceosome mutations in hematopoietic malignanciesChristopher N Hahn, Hamish S Scott
Blood|May 21, 2020
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)Anna L Brown, Christopher N Hahn, Hamish S Scott
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 22, 2022
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopeniasSimone Feurstein, Christopher N Hahn, Nikita Mehta, et al.
Immunological Reviews|December 17, 2014
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancyChristopher N Hahn, Parvathy Venugopal, Hamish S Scott, et al.
Current Hematologic Malignancy Reports|August 20, 2022
Role of Germline Predisposition to Therapy-Related Myeloid NeoplasmsAnmol Baranwal, Christopher N Hahn, Mithun Vinod Shah, et al.
Blood Cancer Discovery|October 18, 2024
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant MicroenvironmentDeepak Singhal, Monika M Kutyna, Christopher N Hahn, et al.
Leukemia Research|September 24, 2024
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypesJonathan Lim, David M Ross, Anna L Brown, et al.
Blood|June 3, 2004
Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1Xiaochun Li, Christopher N Hahn, Michelle Parsons, et al.
International Journal of Hematology|May 27, 2017
Myeloid neoplasms with germline DDX41 mutationJesse J C Cheah, Christopher N Hahn, Devendra K Hiwase, et al.
Current Hematologic Malignancy Reports|December 15, 2025
Targeting RUNX1 Germline Variants: Agents Under InvestigationSaman Ghalamkari, Christopher N Hahn, Amelia Lau, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Nature Genetics|December 28, 2011
Spliceosome mutations in hematopoietic malignanciesChristopher N Hahn, Hamish S Scott
Blood|May 21, 2020
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)Anna L Brown, Christopher N Hahn, Hamish S Scott
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 22, 2022
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopeniasSimone Feurstein, Christopher N Hahn, Nikita Mehta, et al.
Immunological Reviews|December 17, 2014
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancyChristopher N Hahn, Parvathy Venugopal, Hamish S Scott, et al.
Current Hematologic Malignancy Reports|August 20, 2022
Role of Germline Predisposition to Therapy-Related Myeloid NeoplasmsAnmol Baranwal, Christopher N Hahn, Mithun Vinod Shah, et al.
Blood Cancer Discovery|October 18, 2024
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant MicroenvironmentDeepak Singhal, Monika M Kutyna, Christopher N Hahn, et al.
Leukemia Research|September 24, 2024
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypesJonathan Lim, David M Ross, Anna L Brown, et al.
Blood|June 3, 2004
Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1Xiaochun Li, Christopher N Hahn, Michelle Parsons, et al.
International Journal of Hematology|May 27, 2017
Myeloid neoplasms with germline DDX41 mutationJesse J C Cheah, Christopher N Hahn, Devendra K Hiwase, et al.
Current Hematologic Malignancy Reports|December 15, 2025
Targeting RUNX1 Germline Variants: Agents Under InvestigationSaman Ghalamkari, Christopher N Hahn, Amelia Lau, et al.
Pageof 6